Protoplasma

, Volume 254, Issue 3, pp 1143–1150

Intercellular crosstalk in human malignant melanoma

  • Barbora Dvořánková
  • Pavol Szabo
  • Ondřej Kodet
  • Hynek Strnad
  • Michal Kolář
  • Lukáš Lacina
  • Eliška Krejčí
  • Ondřej Naňka
  • Aleksi Šedo
  • Karel SmetanaJr.
Review Article

DOI: 10.1007/s00709-016-1038-z

Cite this article as:
Dvořánková, B., Szabo, P., Kodet, O. et al. Protoplasma (2017) 254: 1143. doi:10.1007/s00709-016-1038-z

Abstract

Incidence of malignant melanoma is increasing globally. While the initial stages of tumors can be easily treated by a simple surgery, the therapy of advanced stages is rather limited. Melanoma cells spread rapidly through the body of a patient to form multiple metastases. Consequently, the survival rate is poor. Therefore, emphasis in melanoma research is given on early diagnosis and development of novel and more potent therapeutic options. The malignant melanoma is arising from melanocytes, cells protecting mitotically active keratinocytes against damage caused by UV light irradiation. The melanocytes originate in the neural crest and consequently migrate to the epidermis. The relationship between the melanoma cells, the melanocytes, and neural crest stem cells manifests when the melanoma cells are implanted to an early embryo: they use similar migratory routes as the normal neural crest cells. Moreover, malignant potential of these melanoma cells is overdriven in this experimental model, probably due to microenvironmental reprogramming. This observation demonstrates the crucial role of the microenvironment in melanoma biology. Indeed, malignant tumors in general represent complex ecosystems, where multiple cell types influence the growth of genetically mutated cancer cells. This concept is directly applicable to the malignant melanoma. Our review article focuses on possible strategies to modify the intercellular crosstalk in melanoma that can be employed for therapeutic purposes.

Keywords

Melanocyte Melanoma cells Melanoma ecosystem Cancer-associated fibroblast Keratinocyte Cytokine 

Funding information

Funder NameGrant NumberFunding Note
European regional development fund and the state budget of the Czech Republic.
  • CZ.1.05/2.1.00/19.0400
Grantová Agentura České Republiky
  • 16-05534S
Univerzita Karlova v Praze
  • PRVOUK-27
  • UNCE23014
Ministerstvo Školství, Mládeže a Tělovýchovy
  • Project BIOCEV-FAR reg. No. LQ1604
  • BIOCEV (CZ.1.05/1.1.00/02.0109)
National Grid Infrastructure MetaCentrum
  • CESNET LM2015042

Copyright information

© Springer-Verlag Wien 2016

Authors and Affiliations

  • Barbora Dvořánková
    • 1
    • 2
  • Pavol Szabo
    • 1
    • 2
  • Ondřej Kodet
    • 1
    • 2
    • 3
  • Hynek Strnad
    • 4
  • Michal Kolář
    • 4
  • Lukáš Lacina
    • 1
    • 3
  • Eliška Krejčí
    • 1
  • Ondřej Naňka
    • 1
  • Aleksi Šedo
    • 5
  • Karel SmetanaJr.
    • 1
    • 2
  1. 1.Institute of AnatomyCharles University, 1st Faculty of MedicinePragueCzech Republic
  2. 2.BIOCEVVestecCzech Republic
  3. 3.Department of Dermatology and VenerologyCharles University, 1st Faculty of Medicine and General University Hospital in PraguePragueCzech Republic
  4. 4.Institute of Molecular Genetics, Academy of Sciences of the Czech RepublicPragueCzech Republic
  5. 5.Institute of Biochemistry and Experimental OncologyCharles University, 1st Faculty of MedicinePragueCzech Republic

Personalised recommendations